88 related articles for article (PubMed ID: 9252710)
1. Lentinan potentiates immunity and prolongs the survival time of some patients.
Matsuoka H; Seo Y; Wakasugi H; Saito T; Tomoda H
Anticancer Res; 1997; 17(4A):2751-5. PubMed ID: 9252710
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Tsurumoto S
Anticancer Res; 1995; 15(5B):2291-6. PubMed ID: 8572640
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
Yoshino S; Tabata T; Hazama S; Iizuka N; Yamamoto K; Hirayama M; Tangoku A; Oka M
Anticancer Res; 2000; 20(6C):4707-11. PubMed ID: 11205205
[TBL] [Abstract][Full Text] [Related]
4. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
5. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
[TBL] [Abstract][Full Text] [Related]
7. Transplenic and transtumoral in vivo immunostimulation: effect on cellular immunity parameters.
Boura P; Kountouras J; Lygidakis NJ; Safioleas M; Aphinives P
Hepatogastroenterology; 1999; 46(26):799-803. PubMed ID: 10370616
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
Obi Y
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer.
Shimizu K; Watanabe S; Watanabe S; Matsuda K; Suga T; Nakazawa S; Shiratori K
Hepatogastroenterology; 2009; 56(89):240-4. PubMed ID: 19453066
[TBL] [Abstract][Full Text] [Related]
11. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
12. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
13. [Immune modulatory and therapeutic effect of lentinan on condyloma acuminatum].
Yin G; Yu J; Li D
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Nov; 18(11):665-7. PubMed ID: 11477860
[TBL] [Abstract][Full Text] [Related]
14. Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma.
Cao ZX; Chen XP; Wu ZD
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):562-5. PubMed ID: 14627520
[TBL] [Abstract][Full Text] [Related]
15. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
16. Flow-cytometric analysis of T-lymphocyte subsets after different treatment methods in patients with pericoronitis.
Orbak R; Dayi E
J Oral Maxillofac Surg; 2003 Feb; 61(2):201-5. PubMed ID: 12618998
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma.
Isoda N; Eguchi Y; Nukaya H; Hosho K; Suga Y; Suga T; Nakazawa S; Sugano K
Hepatogastroenterology; 2009; 56(90):437-41. PubMed ID: 19579616
[TBL] [Abstract][Full Text] [Related]
18. Lentinan has a stimulatory effect on innate and adaptive immunity against murine Listeria monocytogenes infection.
Kupfahl C; Geginat G; Hof H
Int Immunopharmacol; 2006 Apr; 6(4):686-96. PubMed ID: 16504933
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2).
Abdel-Wahab M; El-Shennawy F; Agha S; Ragab E; Fathi O; Sultan A; Elghawalby N; Ezzat F
Hepatogastroenterology; 1999 May; 46 Suppl 1():1293-6. PubMed ID: 10429977
[TBL] [Abstract][Full Text] [Related]
20. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis].
Yoshino S; Oka M; Hazama S; Suzuki T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1588-91. PubMed ID: 2389953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
